SCHEMBL4010946

SCHEMBL4010946

CCCCc1nc(=O)c(Br)c(C)n1Cc1ccc(-c2ccccc2C#N)cc1

nearest known ligand 0.56

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.56
AGTR1 P30556 3/20 0.51
ACHE P22303 1/20 0.50
AGTR2 P50052 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4017527 0.87 PPARG (0.55) PPARGAGTR1ACHEAGTR2
SCHEMBL4315568 0.87 PPARG (0.55) PPARGAGTR1ACHEAGTR2
SCHEMBL1894638 0.86 PPARG (0.56) PPARGAGTR1ACHE
SCHEMBL4009715 0.85 PPARG (0.53) PPARGAGTR1ACHEAGTR2
SCHEMBL12716740 0.85 PPARG (0.61) PPARGAGTR1ACHEAGTR2
SCHEMBL1891211 0.84 PPARG (0.56) PPARGAGTR1ACHEAGTR2
SCHEMBL4013409 0.84 PPARG (0.52) PPARGAGTR1ACHEAGTR2
SCHEMBL9402036 0.83 PPARG (0.66) PPARGAGTR1ACHEAGTR2
SCHEMBL4010668 0.83 PPARG (0.63) PPARGAGTR1ACHE
SCHEMBL9843820 0.83 PPARG (0.57) PPARGAGTR1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009133970-A1 CRYSTALLINE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-11-05 WO disclosed
EP-2074117-A2 HETEROMONOCYCLIC COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2009-07-01 EP disclosed
WO-2008062905-A2 HETEROMONOCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-05-29 WO disclosed